Menu
 

Search abstracts


Impact of pear1 gene polymorphisms on clinical outcomes of chinese acute coronary syndrome patients

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Presentation
  • By: QIN, Sibei (PEKING UNIVERSITY HEALTH SCIENCE CENTER, China)
  • Co-author(s): Si-Bei Qin: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
    Xiao-Yan NIE: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
    Yu FU: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
    Jun-Lei LI: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
    Guang-Kai LIANG: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
    Lu-Wen SHI: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
    Hong SHAO: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Sciences, PEKING UNIVERSITY HEALTH SCIENCE CENTER, Beijing, China
    Jian LIU: Department of Cardiology, Peking University People’s Hospital, Beijing, China
  • Abstract:

    Background

    Genetic polymorphism might be an explanation to the individual variation in dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. Platelet Endothelial Aggregation Receptor-1 (PEAR1) is a platelet transmembrane protein which plays a crucial role in platelet aggregation. Previous studies implicate polymorphism of PEAR1 is

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses